W3C home > Mailing lists > Public > public-semweb-lifesci@w3.org > October 2006

NIH Request for Information (RFI): To Solicit Input and Ideas for Roadmap Trans-NIH Strategic Initiatives

From: Eric Neumann <eneumann@teranode.com>
Date: Tue, 31 Oct 2006 08:23:05 -0500
To: "W3C HCLSIG" <public-semweb-lifesci@w3.org>
Message-ID: <300AA674-28F8-4FC9-8DF8-6F2E596D2E95@teranode.com>

http://grants.nih.gov/grants/guide/notice-files/NOT-OD-07-011.html


I am posting this to the HCLS group, since we may want to consider  
being one of the responders to this RFI...


[Excerpt]
Request for Information

This RFI invites input and ideas from the scientific community,  
health professionals, patient advocates, and the general public on  
ways to:

address specific barriers to basic, translational, or clinical  
research through development of novel tools, technologies, services,  
etc.
fill knowledge gaps that impede research across a broad spectrum of  
health science .
We invite you to submit individual ideas and/or to view the ideas  
that have been submitted to date. All ideas should meet the following  
criteria for new trans-NIH strategic initiatives :

Is the proposed initiative truly transforming –could it dramatically  
affect how biomedical and/or behavioral research is conducted over  
the next decade?

Will the outcomes from the proposed initiatives synergistically  
promote and advance the individual missions of the Institutes and  
Centers to benefit health?

Does the proposed initiative require participation from NIH as a  
whole and/or does it address an area (s) of science that does not  
clearly fall within the mission of any one IC or OD program office?

Is the proposed initiative something that no other entity is likely  
or able to do, and is there a public health benefit to having the  
results of the research in the public domain ?

In addition to these general criteria, selection of initiatives will  
be based on whether the proposed programs can either be achieved  
within a 5-10 year time frame or can be expected to become integrated  
with IC funded research within that time frame. The selection will  
also take into consideration current research funding, with the  
intent of stimulating research in new or fledgling research areas  
that also meet all of the criteria stated above. The ideas should not  
be disease specific and should not address problems or opportunities  
that fall under the purview of one NIH Institute or Center.




Eric Neumann, PhD
co-chair, W3C Healthcare and Life Sciences,
and Senior Director Product Strategy
Teranode Corporation
411 1st Avenue South, Suite 700
Seattle, WA 98104
+1 (781)856-9132
www.teranode.com
Received on Tuesday, 31 October 2006 13:23:28 GMT

This archive was generated by hypermail 2.3.1 : Tuesday, 26 March 2013 18:00:45 GMT